, /PRNewswire/ — ACCC has collaborated with Eli Lilly and Company to issue a Request for Proposals (RFP) aimed at funding Quality Improvement (QI) and Implementation Science (IS) initiatives to reduce clinical care gaps for patients with solid tumors. The RFP invites community hospital-based programs and physician group practices to apply for individual grant requests up to $150,000 to address the most significant points of patient loss along the precision oncology care pathway. In total, Lilly will provide $1 million in funding for these QI grants.
“Precision medicine requires a deep understanding of the nuances of tumor molecular testing, but also a systematic plan for implementation and integration into everyday practice,” said ACCC member Stacy Cohen, MD. “Through this grant program, ACCC member programs and practices are offered a unique opportunity to explore quality improvement initiatives that expedite the implementation and sustainability of precision oncology efforts within their own health systems.”
“Lilly is excited to collaborate with ACCC …